Form 10-Q · Quarterly report
Fastenal 10-Q, filed Jul 16, 2026
- Filed
- CIK
- 0000815556
- Accession no.
- 0000815556-26-000041
Summary
Fastenal reported second-quarter 2026 net sales of $2.39 billion, up 14.7% from a year earlier, with net income of $382.8 million, up 15.9%, and diluted earnings per share of $0.33 versus $0.29. The company lowered its 2026 goal for weighted FASTBin and FASTVend device signings to 27,000–29,000 MEUs from a prior 28,000–30,000.
Key points
- Second-quarter 2026 operating income was $501.8 million, or 21.0% of net sales, versus $436.1 million a year earlier.
- Gross profit margin slipped to 44.6% of net sales from 45.3%, while SG&A fell to 23.5% of net sales from 24.4%.
- Product pricing added roughly 290 basis points to second-quarter sales growth, compared with 140 to 170 basis points in the 2025 quarter.
- Fastenal signed 6,993 weighted FASTBin and FASTVend devices in the quarter, up 8.3% year over year, with 140,789 weighted installations at period end.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2 — MANAGEMENT'S DISCUSSION Executive Overview The following table presents a performance summary of our results of operations for the six- and three-month periods ended June 30, 2026 and 2025. Six-month Period Three-month Period 2026 2025 Change 2026 2025 Change Net sales $ 4,588.6 4,039.7 13.6 % $ 2,386.9 2,080.3 14.7 % Business days 127 127 64 64 Daily sales $ 36.1 31.8 13.6 % $ 37.3 32.5 14.7 % Gross profit $ 2,046.6 1,826.7 12.0 % $ 1,063.6 942.8 12.8 % % of net sales 44.6 % 45.2 % 44.6 % 45.3 % SG&A expenses $ 1,097.2 996.7 10.1 % $ 561.8 506.7 10.9 % % of net sales 23.9 % 24.7 % 23.5 % 24.4 % Operating income $ 949.4 830.0 14.4 % $ 501.8 436.1 15.1 % % of net sales 20.7 % 20.5 %…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.